Search

everythinglearnresearchcommunity

for

Search:↓

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Topical testosterone can cause acne-like skin changes.

Clascoterone cream could be used for other skin conditions affected by hormones.

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Some infants temporarily grow scrotal hair, which usually disappears on its own without any health issues.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The risks of testosterone implants in women outweigh the benefits.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Clascoterone is safe for the heart, even at high doses.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The study created a new method to test drugs that affect hormone processing in skin.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

The niosomal gel effectively delivers testosterone through the skin with fewer side effects.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.